Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma have?
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma has 424 citations in the OpenAlex counts ScholarIQ stores.
When was Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma published?
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma has 2015 year in the ScholarIQ index.
What is the open-access status of Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma?
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma has hybrid oa status in the ScholarIQ index.
What is the DOI of Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma?
The DOI for Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma is on the source record.
What is the PMID of Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma?
The PMID for Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma is on the source record.
What is the OpenAlex record for Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma?
The OpenAlex for Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma is on the source record.